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Objectives: Pott’s disease causing paraplegia is common and
increasing its prevalence in developing countries. It has poor
prognosis due to late diagnosis. Therefore, rapid diagnosis
is essential to decrease the morbidity and mortality of
this disease. Conventional laboratory diagnosing methods
are time consuming and also suffers from low sensitivity.
The present study was undertaken with an aim to assess
the applicability of rapid methods such as PCR with the
traditional BACTEC culture and Microscopic detection of
Mycobacterium complex (MTBC) in spinal specimens.
Methods: Sixty two samples of suspected cases of Pott’s
disease were included in this study. They were processed
for Ziehl-Neelsen staining for acid fast bacilli (AFB) and
BACTEC culture for M. tuberculosis. Further, they were also
processed for PCR ampliﬁcation of insertion element IS6110
of M. tuberculosis complex. The Sensitivity, speciﬁcity and
positive-negative predictive value were assessed and also
Kappa coefﬁcient calculated for agreement culture between
these tests.
Results: Out of 62 suspected Pott’s spine cases 34 were male
and 28 were female ranging the age between 12 to 78 yrs.
As all these samples were tested against Mycobacterium
by the different methods and ZN staining detected AFB
in 19 (30.6%); BACTEC culture was positive for MTBC in
27 (43.5%) and PCR detected MTBC in 33 (53.2%) of the above
tested cases. Considering BACTEC culture as gold standard,
the sensitivity, speciﬁcity, positive and negative predictive
values (PPV&NPV) were 96%, 80%, 79%, 97% correspondingly
for the PCR test and for ZN staining they were 52%, 91%, 82%
and 71% respectively. Kappa agreement between cultures
with ZN and culture with PCR is k 0.51 & 0.75 respectively.
Conclusion: PCR results showed a good agreement with
BACTEC culture. Further, the results also suggests that PCR is
useful for early diagnosis of tuberculosis in spinal samples.
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Background: Non-tuberculous mycobacteria (NTM) causing
clinical disease have become increasingly common and
more diverse. A new reverse line probe assay, GenoType
Mycobacterium CM (Hain Lifescience), was evaluated for
the ability to differentiate mycobacterial species.
Methods: Culture positive isolates were analyzed using
colloidal gold method and 16S rRNA gene PCR and
sequencing. A total of 18 clinical isolates were identiﬁed.
Result: According to the result of the 16S rRNA sequencing,
2 strains (11.1%) were identiﬁed as Mycobacterium
tuberculosis (MTB). Concordant results between the
GenoType Mycobacterium assay and 16S rRNA sequencing
were obtained in 18/18 clinical isolates (100%). But for
colloidal gold method, 1 Non-tuberculosis Mycobacterium
(NTM) strain was classiﬁed as MTB while 1 MTB strain was
classiﬁed as NTM and the total concordant rate was 88.9%.
Conclusion: In conclusion, the GenoType Mycobacterium
CM assay represents a useful tool to rapidly identify
mycobacterial clinical isolates. The molecular system is
as rapid and reliable as the 16S rRNA sequencing, but more
accurate than the colloidal gold method.
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Background: Current chemotherapy of tuberculosis (TB)
has been rendered quite ineffective by the emergence
of resistant strains worldwide and ineffective strategies
against latent tuberculosis infection. A rational approach
is to develop/improve existing drugs to be used as
new antitubercular agents. Phenothiazines, particularly
thioridazine has documented in vitro activity against various
strains of M. tuberculosis. Further, it has been shown that
Phenothiazine analogues speciﬁcally inhibit type-II NADH
dehydrogenase and may be effective in preventing the
transition of M. tuberculosis from actively growing to non-
replicating stage during chronic infections. The present
study was designed to evaluate their in vitro and in vivo
killing efﬁcacies against active and latent TB.
Methods: Thioridazine was evaluated for its in vitro
and in vivo inhibitory activity against active and latent
M. tuberculosis.
Results: Thioridazine was found to be effective against
M. tuberculosis with a MIC of 10 mg/ml. Thioridazine showed
synergistic activity with front-line antituberculosis drugs
Rifampicin and Isoniazid even at sub-MIC concentrations.
In vivo studies conﬁrmed the accumulation of Thioridazine
in the alveolar macrophages. When Thioridazine was used
in combination with Rifampicin and Isoniazid in a short-
course chemotherapy model of experimental tuberculosis,
it showed more potent activity than a combination of
Rifampicin and Isoniazid. Similar results were observed
in 6-week extended chemotherapy for experimental
tuberculosis, when thioridazine was used as an adjunct
drug in the standard regimen. Thioridazine also showed
promising activity against in vitro and in vivo models of
latent tuberculosis, where it was able to kill dormant/latent
bacilli effectively.
Conclusions: Thioridazine has shown potential in vitro and
in vivo activity against both active and latent tuberculosis.
Our observations clearly show that phenothiazines,
especially thioridazine may be considered as an adjunct
drug for improving the chemotherapy of tuberculosis.
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Objective: To explore the clinical curative effect of
intrapleural injection of Tissue Plasminogen Activator (t-PA)
in the prevention of pleural loculated effusions by infective
pleurisy.
Methods: 32 patients with loculated effusions were
randomized into 2 groups, intrapleural Tissue Plasminogen
Activator therapy group and conventional group (control
group). The patients in therapy group were injected
with t-PA 10mg and saline 50ml intrapleurally after each
